Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
SC01 - Staging Before and After Induction Therapy for N2 Disease
- Type: Science Session
- Track: Radiology/Staging/Screening
- Presentations: 6
- Moderators:G. Mostbeck
- Coordinates: 12/05/2016, 11:00 - 12:30, Lehar 3-4
-
+
SC01.01 - The Importance of Mediastinal Down-Staging During Induction Therapy of N2 Disease
11:00 - 11:20 | Author(s): P. De Leyn
- Abstract
Loading...
-
+
PC01 - Pro Con Session: Invasive Mediastinal Staging for N2 Disease
- Type: Pro Con
- Track: Radiology/Staging/Screening
- Presentations: 4
- Moderators:W. Weder
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall C2
-
+
PC01.02 - Invasive Staging and Restaging
14:40 - 15:00 | Author(s): C. Dooms
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.02 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Locally Advanced NSCLC
- Presentations: 62
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.02-045 - Prognostic Value of Metabolic FDG-PET Response in Locally Advanced NSCLC: A Literature Review
14:30 - 14:30 | Author(s): C. Dooms
- Abstract
Loading... -
+
P2.02-055 - Pathologic Mediastinal Nodal and Metabolic Tumor Response to Predict Overall Survival in Stage IIIA-N2 NSCLC after Neoadjuvant Chemotherapy
14:30 - 14:30 | Author(s): C. Dooms
- Abstract
Loading...